Viewing Study NCT04847557


Ignite Creation Date: 2025-12-24 @ 7:03 PM
Ignite Modification Date: 2025-12-29 @ 9:19 PM
Study NCT ID: NCT04847557
Status: COMPLETED
Last Update Posted: 2025-08-20
First Post: 2021-02-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
Sponsor: Eli Lilly and Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 17757
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators